533212 — GKB Ophthalmics Income Statement
0.000.00%
- IN₹387.62m
- IN₹541.42m
- IN₹1.09bn
- 31
- 59
- 19
- 26
Annual income statement for GKB Ophthalmics, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 569 | 709 | 755 | 883 | 1,090 |
Cost of Revenue | |||||
Gross Profit | 198 | 261 | 281 | 285 | 355 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 588 | 688 | 746 | 906 | 1,149 |
Operating Profit | -19.5 | 21.8 | 8.56 | -23.2 | -58.7 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -15.5 | 18.5 | 1.06 | -27.2 | -69.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | -13.7 | 18.5 | 0.831 | -29.2 | -72.6 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -9.07 | 12.7 | -1.67 | -28.1 | -70.4 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -9.07 | 12.7 | -1.67 | -28.1 | -70.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.87 | 2.53 | -0.42 | -5.63 | -14 |